A 34-patient US study published in Frontiers in Neurology showed use of Australian medtech company Neurotech International's Mente Autism electroencephalogram device to treat children with autism led to a significant decrease in delta, beta and high beta brain waves, better balance with eyes open, improved social and communication skills and reductions in autistic behaviors over 12 weeks. Use of a sham device demonstrated little change across the range of functional areas.
Study shows positive results for Neurotech's autism treatment device
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.